Page 55 - 80_04
P. 55
Riesgo y seguridad de la terapia avanzada
14. Bernardo, ME.; Fibbe, WE. Safety and efficacy of mesenchymal stromal cell therapy in
autoimmune disorders. Ann N Y Acad Sci 1266, 107-117 (2012).
15. Benoit, E.; O'Donnell, TF.; Patel, AN. Safety and efficacy of autologous cell therapy in
critical limb ischemia: a systematic review. Cell Transplant, 22(3), 545-562 (2013)
16. Wu, C.; Dunbar, CE. Stem cell gene therapy: the risks of insertional mutagenesis and
approaches to minimize genotoxicity. Front Med 5(4), 356-371 (2011).
17. Mukherjee, S.; Thrasher AJ. Gene therapy for PIDs: progress, pitfalls and prospects. Gene
525(2), 174-181 (2013).
693
